CONTACT US   |  (864) 397-5101

GE HealthCare launches AI feature on certain ultrasound systems for cardiac care

GE Healthcare for Website.

Courtesy of First Word HealthTech

GE HealthCare on Friday announced the US launch of the artificial intelligence (AI)-driven Caption Guidance feature on its Venue Family point-of-care ultrasound systems. The AI technology provides real-time guidance to users for capturing diagnostic-quality cardiac images.

Dietmar Seifriedsberger, global general manager of point-of-care and handheld ultrasound, remarked that the “AI software is expected to increase the number of clinicians who can successfully and confidently conduct cardiac ultrasound scans.” Karley Yoder, chief digital officer of ultrasound, added that the company plans to expand the use of the AI technology “to maternal, foetal and pulmonary diseases.”

According to GE HealthCare, the AI-driven technology provides clinicians “step-by-step instructions” to acquire ultrasound images for cardiac assessments, addressing training and skill barriers to ultrasound usage. The company said it plans to integrate the AI technology into other ultrasound systems, including handheld systems, helping to further broaden the use of ultrasound in a variety of care settings.

The Venue Family ultrasound systems are the first to incorporate the AI technology following the company’s acquisition of Caption Health in February. The technology was launched in the US in 2020 and gained the CE mark last year.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.